Clinical Trial Update: Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating the safety and efficacy of Meta10-GPC3 GPC3-targeted CAR-T cells in unresectable recurrent/metastatic hepatocellular carcinoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Meta10-GPC3 CAR-T cells (GPC3-targeted CAR-T cells)

Snippet

Sponsor: Zhejiang University | Conditions: Hepatocellular Carcinoma (HCC) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING